NCAPG and breast cancer: Consistently, our study demonstrated that expression of NCAPG is increased in trastuzumab-resistant BC, and NCAPG overexpression promotes the proliferative and anti-apoptotic cell features, while silencing NCAPG re-sensitized the response to trastuzumab in trastuzumab-resistant HER2+ BC.